In a step likely to advance personalized cancer treatment, scientists have—for the first time—shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
Nov 22, 2022
0
69
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup ...
Nov 22, 2022
0
41
A cup of ruby red hibiscus tea not only warms the body in winter but is also known to boost the immune system, control blood pressure, and reduce body weight. And here is yet another reason to enjoy this tea—it may help ...
Nov 16, 2022
0
41
COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS. This is the conclusion of a study from Linköping University ...
Nov 16, 2022
0
103
A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective.
Nov 11, 2022
0
55
Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against COVID-19 could reduce the success of cancer treatment ...
Nov 8, 2022
0
5
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
Significantly more adults with dermatomyositis receiving intravenous immune globulin (IVIG) versus placebo have a response of at least minimal improvement, according to a study published in the Oct. 6 issue of the New England ...
Oct 6, 2022
0
17
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body's immune system attacks the nerves, according to a Rutgers-led study.
Oct 4, 2022
0
80
Despite recent advancements in our knowledge of the pathogenic mechanisms of ulcerative colitis, there is still a considerable unmet medical need for the treatment of the condition.
Sep 29, 2022
0
6
